EC
NXTC icon

EcoR1 Capital’s NextCure NXTC Stock Holding History

EcoR1 Capital’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20,875
Closed -$7.73M – 50
2019
Q3 		$7.73M Buy
+20,875
New +$6.79M 0.98% 21

Other funds holding NXTC

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

EcoR1 Capital's NXTC Position: Q4 2019 in Review

EcoR1 Capital sold out of NextCure (NXTC) in Q4 2019, closing a stake of 20,875 shares — an estimated $7.73M sold.

EcoR1 Capital first reported a position in NXTC in Q3 2019 and held it in 1 quarter. The position peaked at $7.73M in Q3 2019. 88 funds tracked by Wall St. Rank hold NXTC as of Q4 2019.

  • EcoR1 Capital reported no remaining NextCure position as of Q4 2019 after selling out during the quarter.
  • EcoR1 Capital sold 20,875 NextCure shares in Q4 2019, an estimated $7.73M.
  • EcoR1 Capital first reported a position in NextCure in Q3 2019 and held it in 1 quarter.
  • EcoR1 Capital's NextCure position peaked at $7.73M in Q3 2019.
  • 88 funds tracked by Wall St. Rank held NextCure as of Q4 2019.

Based on EcoR1 Capital's 13F filing for Q4 2019, filed 14 Feb 2020.